Avalo Therapeutics Inc
F:C6K
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Avalo Therapeutics Inc
F:C6K
|
US |
|
L
|
Lloyds Banking Group PLC
XMUN:LLD
|
UK |
|
C
|
China Mobile Ltd
XMUN:CTM
|
CN |
Intrinsic Value
The intrinsic value for
Avalo Therapeutics Inc (C6K) under the Base Case is 0.518 EUR.
Compared with the current market price of 2.488 EUR, the stock appears
Overvalued by 79% .
Both DCF and multiples point to overvaluation.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Avalo Therapeutics Inc.
Fundamental Analysis
Revenue & Expenses Breakdown
Avalo Therapeutics Inc
Earnings Waterfall
Avalo Therapeutics Inc
The intrinsic value for
Avalo Therapeutics Inc (C6K) under the Base Case is 0.518 EUR.
Compared with the current market price of 2.488 EUR, the stock appears Overvalued by 79% .